Cargando…
Erlotinib induces the human non–small‐cell lung cancer cells apoptosis via activating ROS‐dependent JNK pathways
Although erlotinib (ERL) has drawn more and more attention toward its anticancer properties effect, the underlying mechanisms of ERL's anticancer properties effect remain unclear yet. So, the aim of this research was to explore the underlying anticancer mechanisms of ERL and to explore whether...
Autores principales: | Shan, Fenglian, Shao, Zewei, Jiang, Shenghua, Cheng, Zhaozhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119972/ https://www.ncbi.nlm.nih.gov/pubmed/27726288 http://dx.doi.org/10.1002/cam4.881 |
Ejemplares similares
-
Increased expression of miR‐641 contributes to erlotinib resistance in non‐small‐cell lung cancer cells by targeting NF1
por: Chen, Juan, et al.
Publicado: (2018) -
Tumor-promoting function of apoptotic caspases by an amplification loop involving ROS, macrophages and JNK in Drosophila
por: Pérez, Ernesto, et al.
Publicado: (2017) -
XEDAR inhibits the proliferation and induces apoptosis of gastric cancer cells by regulating JNK signaling pathway
por: Yang, Lihong, et al.
Publicado: (2019) -
PRDM5 promotes the proliferation and invasion of murine melanoma cells through up‐regulating JNK expression
por: Wang, Lei, et al.
Publicado: (2016) -
Overexpression of PRDM5 promotes acute myeloid leukemia cell proliferation and migration by activating the JNK pathway
por: Zhou, Pan, et al.
Publicado: (2019)